MONO INSTITUTIONAL EXPERIENCE IN NON SMALL LUNG CANCER WITH EML4-ALK REARRANGEMENT

被引：0
|
作者：
Perez Mesa, Pablo Jose [1 ]
Guadalupe Pallotta, Maria [1 ]
De La Iglesia, Paola [2 ]
Lupinacci, Lorena [1 ]
Liliana Dalurzo, Mercedes [2 ]
机构：
[1] Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina
[2] Hosp Italiano Buenos Aires, Dept Pathol, Buenos Aires, DF, Argentina
来源：
JOURNAL OF THORACIC ONCOLOGY | 2014年 / 9卷 / 09期
关键词：
EML4-ALK;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.29
引用
收藏
页码：S170 / S170
页数：1
相关论文
共 50 条
  • [21] EML4-ALK Fusion in Lung
    Mano, Hiroyuki
    Takeuchi, Kengo
    AMERICAN JOURNAL OF PATHOLOGY, 2010, 176 (03): : 1552 - 1553
  • [22] Monitoring rearrangement of EML4-ALK in blood platelets predicts outcome to crizotinib treatment in non -small -cell lung cancer patients
    Nilsson, Jonas A.
    Karachaliou, Niki
    Schellen, Pepijn
    Gimenez-Capitan, Ma
    Berenguer, Jordi
    Teixido, Cristina
    Kulper, Justine L.
    Drees, Esther
    Grabowska, Magda
    van Keulen, Marte
    Tannous, Jihane M.
    Heideman, Danielle A. M.
    Thunnissen, Erik
    Dingemans, Anne-Marie C.
    Viteri, Santiago
    Tannous, Bakhos A.
    Drozdowskyj, Ana
    Rosell, Rafael
    Smits, Egbert F.
    Wurdinger, Thomas
    CANCER RESEARCH, 2015, 75
  • [23] Primary resistance to crizotinib treatment in a non-small cell lung cancer patient with an EML4-ALK rearrangement:a case report
    Ling Zhang
    Yunxia Li
    Shaohong Zhang
    Chen Gao
    Keke Nie
    Youxin Ji
    Cancer Biology & Medicine, 2018, (02) : 178 - 181
  • [24] Primary resistance to crizotinib treatment in a non-small cell lung cancer patient with an EML4-ALK rearrangement: a case report
    Zhang, Ling
    Li, Yunxia
    Zhang, Shaohong
    Gao, Chen
    Nie, Keke
    Ji, Youxin
    CANCER BIOLOGY & MEDICINE, 2018, 15 (02) : 178 - 181
  • [25] Reliability Assurance of Detection of EML4-ALK Rearrangement in Non-Small Cell Lung Cancer: The Results of Proficiency Testing in China
    Li, Yulong
    Zhang, Rui
    Peng, Rongxue
    Ding, Jiansheng
    Han, Yanxi
    Wang, Guojing
    Zhang, Kuo
    Lin, Guigao
    Li, Jinming
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (06) : 924 - 929
  • [26] Primary resistance to crizotinib treatment in a non-small cell lung cancer patient with an EML4-ALK rearrangement:a case report
    Ling Zhang
    Yunxia Li
    Shaohong Zhang
    Chen Gao
    Keke Nie
    Youxin Ji
    Cancer Biology & Medicine, 2018, 15 (02) : 178 - 181
  • [27] ALK Inhibitors Do Not Increase Sensitivity to Radiation in EML4-ALK Non-small Cell Lung Cancer
    Fleschutz, Kathrin
    Walter, Lisa
    Leistner, Rumo
    Heinzerling, Lucie
    ANTICANCER RESEARCH, 2020, 40 (09) : 4937 - 4946
  • [28] ANALYSIS OF EML4-ALK POSITIVE NON-SMALL CELL LUNG CANCER WITH ADVANCED STAGE
    Park, J.
    Kondo, C.
    Shimizu, J.
    Horio, Y.
    Yoshida, K.
    Yatabe, Y.
    Mitsudomi, T.
    Hida, T.
    ANNALS OF ONCOLOGY, 2012, 23 : 433 - 434
  • [29] EML4-ALK Fusion Gene in Korean Non-Small Cell Lung Cancer Response
    Park, Jae Yong
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2012, 27 (05) : 578 - 578
  • [30] Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer
    Soda, Manabu
    Choi, Young Lim
    Enomoto, Munehiro
    Takada, Shuji
    Yamashita, Yoshihiro
    Ishikawa, Shunpei
    Fujiwara, Shin-ichiro
    Watanabe, Hideki
    Kurashina, Kentaro
    Hatanaka, Hisashi
    Bando, Masashi
    Ohno, Shoji
    Ishikawa, Yuichi
    Aburatani, Hiroyuki
    Niki, Toshiro
    Sohara, Yasunori
    Sugiyama, Yukihiko
    Mano, Hiroyuki
    NATURE, 2007, 448 (7153) : 561 - U3
12345